drugset / Trial / NCT01416493

Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis

NCT01416493 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a proof of concept study asking if alkaline phosphatase injections can reduce acute inflammation in rheumatoid arthritis patients.

Timeline

Start
2011-05
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bovine Intestinal Alkaline Phosphatase Protein / enzyme biologic 2000 iu Subcutaneous

Indications